We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HAYWARD, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH) (โAntheraโ or the โCompanyโ) announced today that it has withdrawn its request for a hearing to...
Sollpura did not achieve the primary endpoint of the coefficient of fat absorption (โCFAโ)Sollpura did achieve the secondary endpoint of coefficient of nitrogen absorption (โCNAโ)Further...
HAYWARD, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...
HAYWARD, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticalsย (Nasdaq:ANTH) today announced that Anthera has received formal notice from The NASDAQ Stock Market LLC (โNasdaqโ...
RESULT study reported positive interim futility analyses and completion of dosing, with top line data expected in March 2018Completed private placement for net proceeds of $13.3 million...
HAYWARD, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...
HAYWARD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH) is pleased to announce that the final patient has completed the last visit in the primary...
HAYWARD, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announcedย that on January 24, 2018, Anthera received formal notice that the Nasdaq...
HAYWARD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced a positive outcome of the second, pre-specified interim futility analysis for...
HAYWARD, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.ย (Nasdaq:ANTH) today announced that it has completed the second closing of the private placement of its equity...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0001 | 100 | 0.0001 | 0.0002 | 1.0E-6 | 72291 | 1.21E-6 | CS |
4 | 0.0001 | 100 | 0.0001 | 0.0002 | 1.0E-6 | 50689 | 5.299E-5 | CS |
12 | 0.000199 | 19900 | 1.0E-6 | 0.0002 | 1.0E-6 | 24866 | 6.39E-5 | CS |
26 | 0.000199 | 19900 | 1.0E-6 | 0.0002 | 1.0E-6 | 17242 | 5.905E-5 | CS |
52 | 0.000199 | 19900 | 1.0E-6 | 0.0002 | 1.0E-6 | 14443 | 4.784E-5 | CS |
156 | 0.0001 | 100 | 0.0001 | 0.008 | 1.0E-6 | 16558 | 8.836E-5 | CS |
260 | -0.0324 | -99.3865030675 | 0.0326 | 0.189 | 1.0E-6 | 89447 | 0.04080608 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions